Incannex Healthcare IXHL
NASDAQ IXHL
$3.42 -0.02 (-0.58%)
At close: Aug 20, 2026 · 2:45 PM UTC

Incannex Healthcare (IXHL) Invested Capital (2024 - 2025)

Incannex Healthcare (IXHL) posted Invested Capital of $1.4 million for Q1 2025, up 1.01% sequentially from $1.4 million in Q4 2024.

Incannex Healthcare (IXHL) Invested Capital (2024 - 2025) Analysis & Trends

Incannex Healthcare has reported Invested Capital for 2 years, with the latest figure at $1.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - 9.90 Bn
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn 4.50 Bn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn 3.74 Bn
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 1.74 Bn
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn -
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn 73.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - 630.00 Mn
10 Incannex Healthcare 42.23 Mn 42.23 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2025 1.40 Mn
Dec 31, 2024 1.38 Mn